Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

v3.21.1
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Jan. 14, 2021
Dec. 21, 2020
Royalty $ 105,000 $ 75,000      
Revenue 198,800        
Accounts receivable related party $ 149,100      
Revenue Benchmark [Member]          
Concentration risk percentage 61.00%        
Accounts Receivable [Member]          
Concentration risk percentage 100.00%        
Securities Exchange Agreement [Member] | Medolife Rx, Inc. [Member]          
Acquisition percentage       51.00% 51.00%
Securities Exchange Agreement [Member] | Dr. Mikaelian [Member]          
Royalty percentage     25.00%    
Royalty     $ 35,000